vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.

GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($104.1M vs $77.6M, roughly 1.3× Bioceres Crop Solutions Corp.). GRID DYNAMICS HOLDINGS, INC. runs the higher net margin — -1.4% vs -9.6%, a 8.2% gap on every dollar of revenue. On growth, GRID DYNAMICS HOLDINGS, INC. posted the faster year-over-year revenue change (3.7% vs -16.8%). Over the past eight quarters, GRID DYNAMICS HOLDINGS, INC.'s revenue compounded faster (12.0% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

BIOX vs GDYN — Head-to-Head

Bigger by revenue
GDYN
GDYN
1.3× larger
GDYN
$104.1M
$77.6M
BIOX
Growing faster (revenue YoY)
GDYN
GDYN
+20.5% gap
GDYN
3.7%
-16.8%
BIOX
Higher net margin
GDYN
GDYN
8.2% more per $
GDYN
-1.4%
-9.6%
BIOX
Faster 2-yr revenue CAGR
GDYN
GDYN
Annualised
GDYN
12.0%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BIOX
BIOX
GDYN
GDYN
Revenue
$77.6M
$104.1M
Net Profit
$-7.4M
$-1.5M
Gross Margin
46.8%
34.8%
Operating Margin
9.3%
61.7%
Net Margin
-9.6%
-1.4%
Revenue YoY
-16.8%
3.7%
Net Profit YoY
-20.2%
-150.6%
EPS (diluted)
$-0.12
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
GDYN
GDYN
Q1 26
$104.1M
Q4 25
$106.2M
Q3 25
$77.6M
$104.2M
Q2 25
$101.1M
Q1 25
$60.6M
$100.4M
Q4 24
$98.8M
$100.3M
Q3 24
$93.3M
$87.4M
Q2 24
$83.0M
Net Profit
BIOX
BIOX
GDYN
GDYN
Q1 26
$-1.5M
Q4 25
$306.0K
Q3 25
$-7.4M
$1.2M
Q2 25
$5.3M
Q1 25
$-1.6M
$2.9M
Q4 24
$605.2K
$4.5M
Q3 24
$-6.2M
$4.3M
Q2 24
$-817.0K
Gross Margin
BIOX
BIOX
GDYN
GDYN
Q1 26
34.8%
Q4 25
34.0%
Q3 25
46.8%
33.3%
Q2 25
34.1%
Q1 25
39.4%
36.8%
Q4 24
42.0%
36.9%
Q3 24
40.2%
37.4%
Q2 24
35.6%
Operating Margin
BIOX
BIOX
GDYN
GDYN
Q1 26
61.7%
Q4 25
0.5%
Q3 25
9.3%
-0.2%
Q2 25
-0.1%
Q1 25
1.5%
-2.0%
Q4 24
14.5%
1.3%
Q3 24
2.5%
2.4%
Q2 24
0.0%
Net Margin
BIOX
BIOX
GDYN
GDYN
Q1 26
-1.4%
Q4 25
0.3%
Q3 25
-9.6%
1.1%
Q2 25
5.2%
Q1 25
-2.6%
2.9%
Q4 24
0.6%
4.5%
Q3 24
-6.6%
4.9%
Q2 24
-1.0%
EPS (diluted)
BIOX
BIOX
GDYN
GDYN
Q1 26
$-0.02
Q4 25
$0.01
Q3 25
$-0.12
$0.01
Q2 25
$0.06
Q1 25
$-0.02
$0.03
Q4 24
$0.00
$0.06
Q3 24
$-0.10
$0.05
Q2 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
GDYN
GDYN
Cash + ST InvestmentsLiquidity on hand
$15.5M
$327.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$530.1M
Total Assets
$734.9M
$605.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
GDYN
GDYN
Q1 26
$327.5M
Q4 25
$342.1M
Q3 25
$15.5M
$338.6M
Q2 25
$336.8M
Q1 25
$38.5M
$325.5M
Q4 24
$29.2M
$334.7M
Q3 24
$32.3M
$231.3M
Q2 24
$256.0M
Stockholders' Equity
BIOX
BIOX
GDYN
GDYN
Q1 26
$530.1M
Q4 25
$542.1M
Q3 25
$288.3M
$537.7M
Q2 25
$532.2M
Q1 25
$345.0M
$517.4M
Q4 24
$346.3M
$517.8M
Q3 24
$346.0M
$400.2M
Q2 24
$388.4M
Total Assets
BIOX
BIOX
GDYN
GDYN
Q1 26
$605.0M
Q4 25
$612.9M
Q3 25
$734.9M
$613.2M
Q2 25
$608.9M
Q1 25
$798.2M
$590.9M
Q4 24
$835.2M
$592.2M
Q3 24
$827.3M
$477.3M
Q2 24
$443.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
GDYN
GDYN
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
GDYN
GDYN
Q1 26
Q4 25
$9.9M
Q3 25
$14.4M
$7.0M
Q2 25
$14.4M
Q1 25
$23.3M
$9.4M
Q4 24
$-5.4M
$7.1M
Q3 24
$5.2M
$9.2M
Q2 24
$10.7M
Free Cash Flow
BIOX
BIOX
GDYN
GDYN
Q1 26
Q4 25
$6.1M
Q3 25
$2.9M
Q2 25
$10.2M
Q1 25
$6.0M
Q4 24
$4.4M
Q3 24
$5.9M
Q2 24
$8.0M
FCF Margin
BIOX
BIOX
GDYN
GDYN
Q1 26
Q4 25
5.7%
Q3 25
2.8%
Q2 25
10.1%
Q1 25
6.0%
Q4 24
4.4%
Q3 24
6.8%
Q2 24
9.7%
Capex Intensity
BIOX
BIOX
GDYN
GDYN
Q1 26
Q4 25
3.6%
Q3 25
3.9%
Q2 25
4.1%
Q1 25
3.3%
Q4 24
2.6%
Q3 24
3.7%
Q2 24
3.2%
Cash Conversion
BIOX
BIOX
GDYN
GDYN
Q1 26
Q4 25
32.34×
Q3 25
5.92×
Q2 25
2.73×
Q1 25
3.21×
Q4 24
-8.85×
1.56×
Q3 24
2.15×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons